In addition, the AKT inhibitor GSK507358A reduced the Stm bacterial burden by 20-fold, but this did not reach statistical significance due to the interindividual variation.
← all excerpts
Identification of kinase inhibitors as potential host-directed therapies for intracellular bacteria.
1
—
—